TABLE 14 FREQUENCY a OF IMPORTANT ADVERSE EVENTS IN THE PHASE 3 STUDY OF BREAST CANCER AFTER FAILURE OF INITIAL CHEMOTHERAPY OR WITHIN 6 MONTHS OF ADJUVANT CHEMOTHERAPY Percent of Patients 175 3 b n 229 135 3 b n 229 Bone Marrow Neutropenia 90 81 28 19 Thrombocytopenia 11 7 3 2 Anemia 55 47 4 2 Infections 23 15 Febrile Neutropenia 2 2 Hypersensitivity Reaction c All 36 31 Severe 0 Peripheral Neuropathy Any symptoms 70 46 Severe symptoms 7 3 Mucositis Any symptoms 23 17 Severe symptoms 3 a Based on worst course analysis priligy dapoxetine 30mg With an estimated failure rate of 4 at 5 years in the control arm, the noninferiority margin of 1
发表于 2024-5-24 17:07:18
